Regina Myers is an Oncology physician affiliated with Children's Hospital of Philadelphia. OpenAlex indexes 167 publications with 2,513 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3401 Civic Center Blvd
Philadelphia, PA 191044319
Telephone
917-837-8472Provider last certified this registry record 17 Oct 2024.
Clinical trials
- Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Sponsor: St. Jude Children's Research Hospital
- Co-administration of CART22-65s and huCART19 for B-ALL
Sponsor: Stephan Grupp MD PhD
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- Jazz Pharmaceuticals Inc.Program year20231 payment
- JAZZ PHARMACEUTICALS INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Optimizing outcomes for children and young adults with relapse of B-cell acute lymphoblastic leukemia after CD19-targeted chimeric antigen receptor T-cell therapy
Children'S Hosp of Philadelphia
FY2026$181,074K08CA277013 - Optimizing outcomes for children and young adults with relapse of B-cell acute lymphoblastic leukemia after CD19-targeted chimeric antigen receptor T-cell therapy
Children'S Hosp of Philadelphia
FY2025$180,885K08CA277013 - Optimizing outcomes for children and young adults with relapse of B-cell acute lymphoblastic leukemia after CD19-targeted chimeric antigen receptor T-cell therapy
Children'S Hosp of Philadelphia
FY2024$179,076K08CA277013
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephan Grupp, MD
Children's Hospital of Philadelphia
John Maris, MD
Children's Hospital of Philadelphia
Stephen Hunger, MD
Children's Hospital of Philadelphia
Jack Rychik, MD
Children's Hospital of Philadelphia
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”